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Summary The risk of cancer in the second degree relatives of a population-based series of children with soft
tissue sarcoma was studied in relation to (i) various characteristics in these relatives, (ii) certain clinical
features in the index children previously identified as risk factors for cancer in their first degree relatives.
Overall there was a non-significant deficit of cancers in the second degree relatives (RR = 0.88) and cancer risk
was unrelated to type or site of cancer, type of relative, or to risk factors in the index case. The findings
indicate that although the families investigated may include a proportion with the Li-Fraumeni cancer family
syndrome, the increased cancer risk already reported in the first degree relatives does not extend to second
degree relatives in general.
Bone and soft tissue sarcomas diagnosed during childhood
and young adult life can occur as part of the Li-Fraumeni
cancer family syndrome. In addition to sarcomas, this syn-
drome includes early onset breast cancer, adrenal cortical
tumours, brain tumours, leukaemia and possibly other malig-
nancies of early onset. The predisposition to cancer in this
syndrome appears to be inherited as an autosomal dominant
(Li & Fraumeni, 1969; Li et al., 1988).
While only a proportion of young people with sarcomas
can be identified as members of Li-Fraumeni families, a
systematic study of a population-based series ofchildren with
soft tissue sarcoia has shown an excess of cancers in their
first degree relatives, particularly breast cancer in the mothers
and paediatric cancers in their siblings (Birch et al., 1990).
An excess of cancers in first degree relatives of a hospital-
based series of 3-year survivors of soft tissue sarcomas has
also been reported by Strong et al. (1987), but no excess risk
for the second degree relatives in this latter series was
demonstrated.
Our own systemic study reported here provided an oppor-
tunity to assess cancer risks to second degree relatives of a
population-based series of children with soft tissue sarcomas
in relation to various clinical features in the index child and
in relation to characteristics in their relatives.
Patients and methods
The study population included all children with soft tissue
sarcoma diagnosed under the age of 15 years and registered
with the Manchester Children's Tumour Registry between
1954 and 1987. The Registry, which is population-based and
has almost complete ascertainment of children with malig-
nant disease in the North Western Regional Health Author-
ity area, is described by Birch (1988). Histopathological
material was reviewed for each case, and the tumours were
classified as described by Birch et al. (1990). Morphology and
primary site of each tumour was coded according to ICD-O
(WHO, 1976).
Parents of the children included in the study were traced
with the help of the Family Practitioner Committees, the
National Health Service Central Register and various local
sources including electoral registers and libraries. Permission
to approach the family for interview was obtained either
from the hospital consultant, if the child was still alive, or
from the parents' General Practitioner. An interview with the
parents or, if they had died, with another close relative was
carried out in the home. In addition to information on first
degree relatives, details of the age at death or last follow-up
and the medical history of all second degree relatives i.e. the
child's grandparents, aunts, uncles, nieces and nephews was
obtained. A postal questionnaire was completed by a small
number of families who had moved some distance from the
region. The sample of cases for whom interviews were
obtained was tested (Chi-squared and Mann Whitney U-test)
to see if it was similar to the non-interviewed sample in terms
of age, sex and histological type.
An attempt was made to confirm all reports of possible
malignant disease in second degree relatives. This was done
initially by checking for an entry in the appropriate Regional
Cancer Register. Where no entry was found or the details of
histology or site were unclear, hospital records were abstract-
ed. If neither cancer registration nor notes were available, a
copy of the death certificate was obtained. The latter proce-
dure related mainly to deaths prior to 1960. Histology of
neoplasms was reviewed in a small number of cases where
information obtained could not be clearly interpreted.
Certain cancers were included in the analysis even where
confirmation was not obtained. This group included relatives
for whom a good history of malignancy was given but who
had died abroad, or for whom all hospital records had been
destroyed and where details of name, date or place of death
were not precise enough for death certification to be traced.
Cancers were classified according to the following ICD-O
groups: carcinomas of trachea and lung; lip, oral cavity and
pharynx; larynx; stomach; colon and rectum; breast; cervix;
kidney; bladder; prostate; and of other and unspecified sites;
central nervous system tumours; leukaemia and lymphoma;
bone and soft tissue sarcoma; melanoma, and other unspeci-
fied malignant tumours. Non-melanoma skin cancers and
benign, borderline and in situ neoplasms were excluded from
analysis.
Expected numbers of cancers in second degree relatives
were calculated using age-, sex-, time period and morpho-
logical type-specific rates derived from the North Western
Regional Cancer Registry statistics. Rates were available for
the period 1970-1984 and those for the years 1970-1974
were applied to years of follow-up occurring in 1965-74,
rates for 1975-79 were applied to years 1975-79, and rates
for 1980-84 to years 1980-88. Years of follow-up and
cancers occurring before 1965 were excluded from analysis.
Because cancer rates for those aged 75 years and over are
thought to be unreliable, all years of follow-up and cancers
occurring over this age were also excluded. Second degree
relatives were included in the analysis up to the first of the
following dates: their 75th birthday, date of death or date of
last follow-up (usually the date of interview). Relatives of
unknown sex, or with unknown date of last follow-up or
with health status unknown were excluded.
Observed numbers of cancers were compared with expect-
ed numbers and a two-tailed Poisson probability calculated.
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Relative risks were estimated by dividing observed by expect-
ed numbers of cancers and 95% confidence intervals were
calculated.
In order to examine cancer risks in more detail, second
degree relatives were partitioned according to their sex, and
by their relationship to the index case (maternal or paternal,
grandparent, paternal sibling, nephew or niece) and observed
and expected numbers of cancers were compared for each
sub-group. In addition observed and expected numbers of
cancers occuring below age 45 years and at 45 years and over
were compared.
The risk to second degree relatives of developing cancers
relevant to the Li-Fraumeni syndrome was also examined. A
model for relative risk in first degree relatives of developing
breast cancer, central nervous system tumour or soft tissue
sarcoma at any age or any malignant tumour under age 45
identified three significant clinical characteristics in the index
child: sex, age at diagnosis and histology (Birch et al., 1990).
In this model an increased risk was associated with: index sex
male, index age at diagnosis less than 24 months, index
histology embryonal rhabdomyosarcoma or certain other
rare and unspecified soft tissue sarcoma. Four risk groups
were defined for the first degree relatives i.e. risk group (1):
relatives of index patients with none of the high risk factors;
risk group (2): relatives of index patients with one of the high
risk factors; risk group (3): relatives of index patients with
two of the high risk factors; and risk group (4): relatives of
index patients with all three high risk factors. The risk of
developing a cancer relevant to the Li-Fraumeni syndrome in
second degree relatives was examined by index sex, index age,
index histology and by risk group defined in the same way as
for the first degree relatives. In addition similar cancer risks
were determined according to the presence or absence of a
cancer characteristic of the Li-Fraumeni syndrome in a first
degree relative. Expected numbers of cancers in second
degree relatives in each of the defined sub-groups were cal-
culated and compared with observed numbers.
Results
There were 177 children included in the study, 104 boys and
73 girls. The most frequent histological type of sarcoma was
rhabdomyosarcoma, including embryonal (58), alveolar (44),
pleomorphic (4) and unspecified (9). A further 52 children
had other specified soft tissue sarcomas and in the remaining
ten cases the type of sarcoma could not be determined. The
tumours were distributed between head and neck (37%),
genitourinary system (13%), abdomen and pelvis (25%),
thorax (9%) and extremities (16%). Median age at diagnosis
for all cases combined was 53 months (interquartile range 24
to 107 months).
Interviews were carried out with 145 families and a further
six families completed a postal questionnaire. In two cases
the parents' General Practitioners did not consider it appro-
priate for them to be approached, and 15 sets of parents
themselves refused to be interviewed. Three index patients
were adopted and one family had emigrated. The remaining
five families were not seen as a suitable relative for interview
could not be identified.
Information was therefore obtained on all second degree
relatives for 85% of the eligible cases. This sample of index
cases for whom interviews were obtained did not differ signi-
ficantly from the non-interview sample in terms of age at
diagnosis (P = 0.5), sex (P = 0.9), or histology (P = 0.5). In
addition some detail on grandparents was available for
another nine families who had been interviewed for previous studies.
Information on a total of 1,846 second degree relatives was
obtained. Of these, 30 parental siblings of unknown sex were
excluded (24 maternal, six paternal). These were mainly still-
births and early infant deaths. In addition a further 196
individuals (81 maternal, 112 paternal, three nephews) were
excluded on grounds of unknown age at death or last follow-
up, or health status not known. Hence a total of 1,620
relatives was ascertained.
Cohort numbers for analysis, however, were lower than the
numbers of relatives ascertained as some of the relatives of
chidren diagnosed in the earlier years of the study, particular-
ly those in the grandparental generation, had died or reached
age 75 years before 1965 and hence did not contribute to
years at risk or observed cancers. The expected numbers of
cancers in nephews and nieces was very small (0.2), and no
cancers were observed so these groups were excluded from
further analysis.
Table I shows expected and observed numbers of different
cancers in all second degree relatives combined. Although a
total of 116 cancers was seen, only 60 cancers could be
included in the analysis as the remaining 56 tumours were
diagnosed prior to 1965 or occurred in relatives aged 75
years and over. The 60 cancers included four malignancies
which were not medically confirmed but where information
was accepted as reliable. No significant excess of any partic-
ular type or site of cancer was observed although there were
excesses of borderline significance of cancer of the stomach
and cancer of the cervix (stomach, RR = 1.91, P = 0.1; cervix
RR = 2.31, P = 0.1), a significant deficit of other and un-
specified carcinoma (RR = 0.33, P = 0.04) and a non-signi-
ficant deficit of all cancers combined (RR = 0.88, P = 0.4).
Table II shows the expected and observed numbers of
cancers in all second degree relatives by age band, by sex and
by relationship to the index case. Although there were varia-
tions in risk for different groups of relatives, no significant
excesses or deficits of cancers was seen. Nor were there any
statistically significant differences between risk for age of
relative (under 45 years, 45 years and over, P = 0.4), sex of
relative (P = 0.4) and relationship to index (maternal, pater-
nal P = 0.3).
Risk to sub-groups of second degree relatives of develop-
ing cancers considered relevant to the Li-Fraumeni syndrome
defined by those clinical features in the index child previously
identified as associated with risk of cancer in the first degree
relatives are shown in Table III. Sixteen relevant cancers
were diagnosed in the second degree relatives, but the risk
model developed for the first degree relatives did not appear
to select a group of second degree relatives with a high
cancer incidence. Furthermore none of these 16 cancers
occurred in relatives of mothers diagnosed with Li-Fraumeni
cancers and only one was seen in relatives of fathers with
such cancers. Expected numbers in each group were however
very small (mothers' relatives, Exp = 0.7, fathers' relatives,
Exp = 0.3).
Discussion
Despite the fact that the first degree relatives of this popu-
lation-based series of children with soft tissue sarcoma show
a highly significant excess of cancers (Birch et al., 1990), the
results reported here reveal no excess of cancers in their
second degree relatives. Second degree relatives in fact appear
to be at reduced risk of cancer and although the deficit seen
was statistically non significant, it is in line with the findings
of Strong et al. (1987) in their study of the families of a
hospital-based series of survivors of childhood soft tissue
sarcoma.
The most likely explanation for the observed deficit is
under-ascertainment of cancers in relatives. Reporting bias is
difficult to test for without obtaining confirmation of health
status or cause of death for every individual included in the
study. As the second degree relatives of the index patient are
the first degree relatives of the individuals interviewed i.e. the
parents and siblings of the index child's parents, the quality
of the information was felt to be reasonably good. Never-
theless it is inevitable that some cancers would not have been
reported, particularly those occurring in relatives of children
diagnosed during the earlier years covered by the study,
because of loss of contact with relatives.
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Table I Cancer risk in second degree relatives ofchildren with soft tissue sarcoma by
cancer type and site
Expected no. Observed no. P Relative
Cancer type or site cancers cancers value risk 95% CI
Carcinoma lung and 16.1 15 0.9 0.93 0.52-1.54
trachea
Carcinoma colon and 7.9 5 0.4 0.63 0.21-1.48
rectum
Carcinoma breast 9.5 8 0.8 0.84 0.36-1.66
Carcinoma stomach 4.7 9 0.1 1.91 0.88-3.64
Carcinoma pancreas 1.9 1 0.9 0.53 0.01-2.93
Carcinoma cervix 2.6 6 0.1 2.31 0.85-5.02
Carcinoma lip, oral cavity, 1.3 0 0.5 - 0-2.84
pharynx
Carcinoma larynx 0.9 1 1.0 1.11 0.03-6.19
Carcinoma prostate 1.8 3 0.5 1.67 0.34-4.87
Carcinoma kidney 1.1 0 0.7 - 0-3.35
Carcinoma bladder 3.0 4 0.7 1.33 0.36-3.41
Carcinoma other and 9.2 3 0.04 0.33 0.07-0.95
unspecified sites
Central nervous system 2.0 2 1.0 1.00 0.12-3.61
Leukaemia and lymphoma 3.7 2 0.6 0.54 0.07-1.95
Bone and soft tissue 0.7 1 1.0 1.43 0.04-7.96
sarcoma
Melanoma 0.7 0 1.0 - 0-5.27
Other malignant tumours 0.9 0 0.8 0-4.10
Table II Cancer risk in second degree relatives of children with soft tissue sarcoma by features in the
elatives
Total no. Expected no. Observed no. P Relative
Sub-groups ofrelatives relatives cancers cancers value risk 95% CI
Age 0-74 yrs 1139 68.0 60 0.4 0.88 0.67-1.14
Age 0-44 yrs* 753 6.8 8 0.7 1.20 0.51-2.32
Age 45 + yrs* 828 61.2 52 0.3 0.85 0.63-1.11
Male relatives 565 35.2 34 0.9 0.97 0.67-1.35
Female relatives 574 32.8 26 0.3 0.79 0.52-1.16
All maternal relatives 567 35.0 35 1.0 1.00 0.70-1.40
All paternal relatives 572 33.0 25 0.2 0.76 0.49-1.12
Maternal grandfather 97 10.9 12 0.8 1.10 0.57-1.92
Maternal grandmother 113 9.5 10 1.0 1.05 0.50-1.94
Paternal grandfather 84 9.3 6 0.4 0.65 0.24- 1.40
Paternal grandmother 103 8.5 6 0.5 0.71 0.26-1.54
Maternal uncle 185 7.5 8 0.9 1.07 0.46-2.10
Maternal aunt 172 7.1 5 0.6 0.70 0.23-1.64
Paternal uncle 199 7.6 8 1.0 1.05 0.45-2.07
Paternal aunt 186 7.7 5 0.4 0.65 0.21-1.51
*Includes all relatives entering and passing through specified age bands.
TableIII Risk toseconddegreerelativesofdevelopingcancerscharacteristicoftheLi-Fraumeni syndrome
by clinical features in the index and by risk group
Total no. Expected no. Observed no. P Relative
Sub-groups ofrelatives relatives cancers cancers value risk 95% CI
Index sex male 660 9.4 10 1.0 1.06 0.51-1.96
Index sex female 479 7.3 6 0.8 0.82 0.30-1.79
Index <2 yrs at diagnosis 297 3.7 5 0.6 1.35 0.44-3.15
Index 2 yrs + at diagnosis 842 13.0 11 0.7 0.85 0.42-1.51
Index histology embryonal RMS 710 10.5 8 0.6 0.76 0.33-1.50
and other rare and unspecified
STS
Index other histologies 429 6.2 8 0.6 1.29 0.56-2.54
Risk group 1 157 2.5 2 1.0 0.80 0.10-2.89
Risk group 2 420 6.4 7 0.9 1.09 0.44-2.25
Risk group 3 439 6.2 5 0.8 0.81 0.26-1.88
Risk group 4 123 1.6 2 1.0 1.25 0.15-4.51
than maternal relatives, raising the issue of whether infor-
mation about the fathers' relatives was less reliable than that
of the mothers' relatives. The effect of this discrepancy is
difficult to assess but it is possible that fathers were less
aware of the diagnosis of malignant disease in their own
families, particularly in their female relatives. In addition
because more mothers than fathers were seen at interview,
mainly as a result of greater mortality in the fathers and
because of separation and divorce, the paternal data in such
interviews may have been less adequate as a result of reduced
contact with the fathers' families.
Although analysis of cancer risk by site or type in second
degree relatives did not reveal any risks significantly different
from those expected (except for other and unspecified car-
cinoma), the risks were not uniformly distributed. Expected
numbers of most cancers were very small, but it is interesting962 A.L. HARTLEY et al.
to note that there was no excess of breast cancer (RR = 0.84,
P = 0.8), in contrast with the findings for the first degree
relatives, whereas more cancers of stomach (RR = 1.91, P =
0.1) and of cervix (RR = 2.31, P = 0.1) than expected were
seen. Some of these results are in line with those of Strong et
al. (1987) who similarly found a deficit of breast cancer, and
an excess of cancer of the cervix. Cancer of the stomach was
not reported separately.
Cancer of the stomach and cancer of the cervix both show
a strong association with social class (Logan, 1982) so the
higher rates found here may reflect the fact that the relatives
ascertained were of a low socioeconomic grouping, although
this could not be determined directly from the data collected.
On the other hand an excess of stomach cancer was found by
Biirki et al. (1987) in the male second degree relatives of a
series of 138 female breast cancer patients. Stomach cancer
and certain cancers characteristic of the Li-Fraumeni syn-
drome were particularly evident in relatives of patients with
the rare histologies of tubular or medullary carcinoma of the
breast in that series. In addition there appeared to be a high
mortality from oesophageal and stomach cancer combined in
relatives of a series of children with soft tissue sarcoma
reported from Italy (Pastore et al., 1987).
A second explanation for the discrepancy in observed and
expected numbers of cancers is of a real effect i.e. that the
second degree relatives in general, even allowing for under-
reporting, may be at lower risk of certain common cancers
than the population in general.
We were not able to test the finding of Strong et al. (1987)
that cancer risk in second degree relatives was elevated by the
presence of a second malignant neoplasm in the index case,
as only two of our cases had developed more than one
cancer. However, the risk in second degree relatives of cer-
tain cancers thought to be relevant to the Li-Fraumeni synd-
rome was unrelated to the factors in the index child identified
as risk indicators for these cancers in the first degree
relatives.
Assuming that predisposition to the Li-Fraumeni syn-
drome is controlled by a single dominant gene, a new muta-
tion in a parent or child would not increase the risk in more
distant relatives and, even if the gene had been transmitted
through the grandparents' generation, only one out of four
grandparents in any one family would be a carrier and only
half the aunts and uncles on that side of the family would
inherit the gene. The postulated gene is probably not com-
pletely penetrant (Li et al., 1988) and this would further
reduce the number of affected relatives. Additionally cancer
is a very common disease and hence only a very small
potential increase in risk would be expected. This may not be
measurable in a relatively small population (Peto, 1980;
Weiss et al., 1982; Majumder et al., 1983).
In conclusion, there is evidence that second degree relatives
of children with soft tissue sarcoma are not at excess risk of
cancer in comparison with individuals in the general popula-
tion. Although the series reported here probably includes a
proportion of families with the Li-Fraumeni syndrome, as
indicated by the highly significant excess of cancers in their
first degree relatives, it is likely that these families often
represent new mutations of the gene which frequently acts in
a lethal fashion and hence is confined in general to nuclear
families, giving rise to few affected extended kindreds. It is
nevertheless important to identify those families at risk and
to determine possible gene carriers so that the appropriate
surveillance and screening can be directed towards the high
risk groups.
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